User profiles for M. Riessland

Markus Riessland

Stony Brook University
Verified email at stonybrook.edu
Cited by 2852

How genetic modifiers influence the phenotype of spinal muscular atrophy and suggest future therapeutic approaches

B Wirth, L Garbes, M Riessland - Current opinion in genetics & …, 2013 - Elsevier
Both complex disorders and monogenetic diseases are often modulated in their phenotype
by further genetic, epigenetic or extrinsic factors. This gives rise to extensive phenotypic …

SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy

M Riessland, B Ackermann, A Förster… - Human molecular …, 2010 - academic.oup.com
Proximal spinal muscular atrophy (SMA) is a common autosomal recessively inherited
neuromuscular disorder determined by functional impairment of α-motor neurons within the spinal …

[HTML][HTML] PLS3 Mutations in X-Linked Osteoporosis with Fractures

…, MC Zillikens, D Micha, M Riessland… - … England Journal of …, 2013 - Mass Medical Soc
<p id="p001">Plastin 3 (PLS3), a protein involved in the formation of filamentous actin (F-actin)
bundles, appears to be important in human bone health, on the basis of pathogenic …

[HTML][HTML] Dysregulation of ubiquitin homeostasis and β-catenin signaling promote spinal muscular atrophy

TM Wishart, CA Mutsaers, M Riessland… - The Journal of …, 2014 - Am Soc Clin Investig
The autosomal recessive neurodegenerative disease spinal muscular atrophy (SMA) results
from low levels of survival motor neuron (SMN) protein; however, it is unclear how reduced …

[PDF][PDF] Neurocalcin delta suppression protects against spinal muscular atrophy in humans and across species by restoring impaired endocytosis

M Riessland, A Kaczmarek, S Schneider… - The American Journal of …, 2017 - cell.com
… TVA was stained with anti-NF-M (Neurofilament M, NEFM, used as neuronal axon and
dendritic marker [Hybridoma-Bank]) and with secondary goat-anti mouse AlexaFluor488 and …

[PDF][PDF] The power of human protective modifiers: PLS3 and CORO1C unravel impaired endocytosis in spinal muscular atrophy and rescue SMA phenotype

…, A Büschges, M Hammerschmidt, M Riessland… - The American Journal of …, 2016 - cell.com
… The recombinant GST-PLS3 protein was circulated over the m columns for 20 min. Afterward,
m columns were washed, and the bound protein fraction was eluted with 95 C Laemmli …

[HTML][HTML] Age-related midbrain inflammation and senescence in Parkinson's disease

T Russo, M Riessland - Frontiers in Aging Neuroscience, 2022 - frontiersin.org
Immune responses are arising as a common feature of several neurodegenerative diseases,
such as Parkinson’s Disease (PD), Alzheimer’s Disease (AD), and Amyotrophic Lateral …

[HTML][HTML] Translating the biology of aging into new therapeutics for Alzheimer's disease: Senolytics

M Riessland, ME Orr - The Journal of Prevention of Alzheimer's Disease, 2023 - Springer
The recent FDA-approval for amyloid lowering therapies reflects an unwavering commitment
from the Alzheimer’s disease (AD) research community to identify treatments for this …

Plastin 3 ameliorates spinal muscular atrophy via delayed axon pruning and improves neuromuscular junction functionality

…, J Milbradt, TF Wunderlich, M Riessland… - Human molecular …, 2013 - academic.oup.com
F-actin bundling plastin 3 (PLS3) is a fully protective modifier of the neuromuscular disease
spinal muscular atrophy (SMA), the most common genetic cause of infant death. The …

SMN regulates axonal local translation via miR-183/mTOR pathway

…, KZ Dover, M Peters, M Riessland… - Human molecular …, 2014 - academic.oup.com
… 50 nm siRNA and 50 nm LNA inhibitors are transfected to cortical neurons. Western blots
were repeated twice with two different biological samples. Data represent mean ± SEM. …